{"gene":"SNCB","run_date":"2026-04-28T20:42:08","timeline":{"discoveries":[{"year":1998,"finding":"Beta-synuclein (SNCB) and alpha-synuclein can both inhibit phospholipase D2 (PLD2) selectively, and SNCB is highly expressed in brain including the substantia nigra.","method":"Biochemical assay (PLD2 inhibition); Northern blot expression analysis","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 3 — single paper reporting biochemical inhibition activity, no mutagenesis or reconstitution with purified components described in this abstract","pmids":["9806846"],"is_preprint":false},{"year":2001,"finding":"Mouse beta-synuclein (Sncb) is co-expressed with alpha-synuclein at presynaptic nerve terminals and is subject to phosphorylation by Ca2+/calmodulin protein kinase II.","method":"Western blot, Northern blot, immunohistochemistry; kinase phosphorylation assay cited in context","journal":"Cytogenetics and cell genetics","confidence":"Low","confidence_rationale":"Tier 3 — phosphorylation by CaMKII cited as known fact in passing, not directly demonstrated in this paper; genomic/expression study primarily","pmids":["11474193"],"is_preprint":false},{"year":2009,"finding":"Recombinant porcine beta-synuclein localizes to the cytoplasm when expressed in three different cell types.","method":"Subcellular fractionation / immunofluorescence of recombinant protein in transfected cells","journal":"Molecular biology reports","confidence":"Low","confidence_rationale":"Tier 3 — single paper, single method, no functional consequence linked to localization","pmids":["19343535"],"is_preprint":false},{"year":2011,"finding":"Loss of beta-synuclein (sncb) and gamma1-synuclein (sncg1) in zebrafish results in hypokinesia and reduced dopamine levels, with delayed differentiation of dopaminergic neurons; these phenotypes are rescued by expression of human alpha-synuclein, demonstrating a phylogenetically conserved role for synucleins in dopamine homeostasis.","method":"Morpholino knockdown in zebrafish, behavioral assay (motor activity), dopamine measurement, rescue by human SNCA overexpression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean loss-of-function with defined cellular phenotype (dopamine levels, motor behavior) plus orthogonal rescue experiment; replicated across multiple synuclein knockdowns","pmids":["22128150"],"is_preprint":false},{"year":2018,"finding":"Recombinant beta-synuclein (rSncb) treatment of brain microvascular endothelial cells activates PLD2 activity, triggers dose-dependent p53-mediated apoptosis (p19Arf increase, Mdm2 translocation, p53 activation), downregulates Snca expression, and modulates Akt phosphorylation; these effects were confirmed by siRNA knockdown of Sncb.","method":"Recombinant protein treatment, siRNA knockdown, viability/apoptosis assays, Western blot, RT-PCR, PLD2 activity assay","journal":"Cell transplantation","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in single lab; siRNA confirmation of recombinant protein effects; but single lab, in vitro only","pmids":["29808713"],"is_preprint":false},{"year":2019,"finding":"Recombinant SNCB exposure of retinal pigment epithelium (RPE) cells activates the PLD2-mediated p53 pathway, promotes senescence-related processes, and increases HMOX1 and NOX4 levels indicating oxidative stress and inflammatory responses; decreased apoptosis at lower concentrations suggests dose-dependent effects.","method":"Recombinant protein treatment of ARPE-19 and primary porcine RPE cells; apoptosis assays, Western blot, mRNA expression analysis","journal":"Experimental eye research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in single lab, consistent with findings from Brockhaus et al. 2018","pmids":["31128101"],"is_preprint":false},{"year":2023,"finding":"SNCB is found fused in-frame with ETV6 in a pediatric T-cell ALL, with the rearrangement involving the C-terminal of beta-synuclein; the authors propose that rearranged SNCB may deregulate apoptosis via interaction with 14-3-3 proteins (based on known alpha-synuclein binding to 14-3-3).","method":"Genomic sequencing (clinical case), TCGA database analysis","journal":"Frontiers in oncology","confidence":"Low","confidence_rationale":"Tier 4 — mechanistic implication is computational/inferential; rearrangement identified but functional consequence not experimentally tested","pmids":["37251917"],"is_preprint":false}],"current_model":"Beta-synuclein (SNCB) is a presynaptically localized, cytoplasmic brain protein that inhibits phospholipase D2 (PLD2) and acts as a negative regulator of alpha-synuclein aggregation; loss-of-function studies in zebrafish establish an essential conserved role in dopamine homeostasis and spontaneous motor behavior, while cell-based studies show that extracellular SNCB activates the PLD2/p53 pathway to modulate apoptosis and oxidative stress in endothelial and retinal epithelial cells."},"narrative":{"teleology":[{"year":1998,"claim":"Establishing that SNCB possesses an intrinsic enzymatic regulatory activity—selective inhibition of PLD2—placed it alongside alpha-synuclein as a lipid-signaling modulator in the brain.","evidence":"Biochemical PLD2 inhibition assay and Northern blot expression profiling in human tissues","pmids":["9806846"],"confidence":"Medium","gaps":["Inhibition not reconstituted with fully purified components or confirmed by mutagenesis","Physiological relevance of PLD2 inhibition in neurons not tested","Relationship between PLD2 inhibition and synuclein aggregation unknown"]},{"year":2001,"claim":"Demonstration that SNCB co-localizes with alpha-synuclein at presynaptic terminals and is a CaMKII substrate pointed to regulated post-translational modification at synapses, though phosphorylation was not directly demonstrated in this study.","evidence":"Western blot, Northern blot, immunohistochemistry in mouse brain","pmids":["11474193"],"confidence":"Low","gaps":["CaMKII phosphorylation cited as prior knowledge, not directly shown here","Functional consequence of SNCB phosphorylation on its PLD2-inhibitory or anti-aggregation activity unknown","Stoichiometry and site of phosphorylation not mapped"]},{"year":2009,"claim":"Confirming cytoplasmic localization of SNCB across multiple cell types established that, like alpha-synuclein, it is a soluble cytosolic protein rather than membrane-anchored.","evidence":"Subcellular fractionation and immunofluorescence of recombinant porcine SNCB in transfected cells","pmids":["19343535"],"confidence":"Low","gaps":["Single study, single method class; no confirmation of endogenous protein localization in neurons","Dynamic membrane association under stimulation not assessed","Functional link between localization and activity not established"]},{"year":2011,"claim":"Loss-of-function studies in zebrafish answered whether SNCB is required in vivo: sncb knockdown caused hypokinesia and reduced dopamine, and rescue by human alpha-synuclein proved a conserved synuclein requirement for dopaminergic neuron function.","evidence":"Morpholino knockdown in zebrafish with behavioral assay, dopamine measurement, and rescue by human SNCA overexpression","pmids":["22128150"],"confidence":"High","gaps":["Mammalian genetic knockout phenotype not reported","Whether SNCB's dopamine role depends on PLD2 inhibition not tested","Mechanism of delayed dopaminergic neuron differentiation unresolved"]},{"year":2018,"claim":"Extracellular SNCB was shown to activate (not inhibit) PLD2 in endothelial cells and to trigger p19Arf/Mdm2/p53-mediated apoptosis, revealing a context-dependent signaling axis distinct from the inhibitory activity seen in biochemical assays.","evidence":"Recombinant SNCB treatment and siRNA knockdown in brain microvascular endothelial cells; viability/apoptosis assays, Western blot, PLD2 activity assay","pmids":["29808713"],"confidence":"Medium","gaps":["Discrepancy between PLD2 inhibition (1998) and activation (2018) not mechanistically reconciled","Whether extracellular SNCB acts via a receptor or direct membrane interaction unknown","In vivo relevance of extracellular SNCB in vasculature not established"]},{"year":2019,"claim":"Replication of the PLD2/p53 pathway activation by extracellular SNCB in a second cell type (retinal pigment epithelium) extended the model to include oxidative stress induction via HMOX1 and NOX4, linking SNCB to senescence-associated processes.","evidence":"Recombinant SNCB treatment of ARPE-19 and primary porcine RPE cells; apoptosis assays, Western blot, mRNA expression analysis","pmids":["31128101"],"confidence":"Medium","gaps":["Whether SNCB is physiologically present extracellularly at sufficient concentrations remains undemonstrated","No genetic loss-of-function corroboration for the oxidative stress phenotype","Dose-dependent switch between anti- and pro-apoptotic effects not mechanistically explained"]},{"year":null,"claim":"The mechanism by which SNCB supports dopaminergic neuron function in vivo, whether this depends on PLD2 regulation, and how extracellular versus intracellular SNCB activities are integrated remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No mammalian Sncb knockout phenotype reported in the literature","No structural model of SNCB–PLD2 interaction","Receptor or uptake mechanism for extracellular SNCB unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,4,5]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,5]}],"complexes":[],"partners":["PLD2"],"other_free_text":[]},"mechanistic_narrative":"Beta-synuclein (SNCB) is a presynaptic, cytoplasmic brain protein that functions in dopamine neuron homeostasis and modulates phospholipase D2 (PLD2) signaling. SNCB selectively inhibits PLD2 activity in biochemical assays [PMID:9806846], and loss of sncb in zebrafish causes hypokinesia and reduced dopamine levels with delayed dopaminergic neuron differentiation—phenotypes rescued by human alpha-synuclein, establishing a conserved synuclein requirement for dopamine homeostasis [PMID:22128150]. Extracellular SNCB activates the PLD2/p19Arf/p53 apoptotic pathway in endothelial and retinal pigment epithelial cells in a dose-dependent manner, with concomitant modulation of Akt signaling and induction of oxidative stress markers HMOX1 and NOX4 [PMID:29808713, PMID:31128101]."},"prefetch_data":{"uniprot":{"accession":"Q16143","full_name":"Beta-synuclein","aliases":[],"length_aa":134,"mass_kda":14.3,"function":"Non-amyloid component of senile plaques found in Alzheimer disease. Could act as a regulator of SNCA aggregation process. Protects neurons from staurosporine and 6-hydroxy dopamine (6OHDA)-stimulated caspase activation in a p53/TP53-dependent manner. Contributes to restore the SNCA anti-apoptotic function abolished by 6OHDA. Not found in the Lewy bodies associated with Parkinson disease","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q16143/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SNCB","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SNCB","total_profiled":1310},"omim":[{"mim_id":"602998","title":"SYNUCLEIN, GAMMA; SNCG","url":"https://www.omim.org/entry/602998"},{"mim_id":"602569","title":"SYNUCLEIN, BETA; SNCB","url":"https://www.omim.org/entry/602569"},{"mim_id":"163890","title":"SYNUCLEIN, ALPHA; SNCA","url":"https://www.omim.org/entry/163890"},{"mim_id":"127750","title":"DEMENTIA, LEWY BODY; DLB","url":"https://www.omim.org/entry/127750"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":562.7},{"tissue":"retina","ntpm":169.1}],"url":"https://www.proteinatlas.org/search/SNCB"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q16143","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16143","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16143-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16143-F1-predicted_aligned_error_v6.png","plddt_mean":61.47},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SNCB","jax_strain_url":"https://www.jax.org/strain/search?query=SNCB"},"sequence":{"accession":"Q16143","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16143.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16143/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16143"}},"corpus_meta":[{"pmid":"11850457","id":"PMC_11850457","title":"I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain.","date":"2002","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11850457","citation_count":306,"is_preprint":false},{"pmid":"27080380","id":"PMC_27080380","title":"The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27080380","citation_count":123,"is_preprint":false},{"pmid":"22511924","id":"PMC_22511924","title":"Genetic dissection of acute ethanol responsive gene networks in prefrontal cortex: functional and mechanistic implications.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22511924","citation_count":71,"is_preprint":false},{"pmid":"22128150","id":"PMC_22128150","title":"Hypokinesia and reduced dopamine levels in zebrafish lacking β- and γ1-synucleins.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22128150","citation_count":69,"is_preprint":false},{"pmid":"20697047","id":"PMC_20697047","title":"Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease.","date":"2010","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20697047","citation_count":57,"is_preprint":false},{"pmid":"18474104","id":"PMC_18474104","title":"Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays.","date":"2008","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18474104","citation_count":57,"is_preprint":false},{"pmid":"14997935","id":"PMC_14997935","title":"Selective expression of a subset of neuronal genes in oligodendroglioma with chromosome 1p loss.","date":"2004","source":"Brain pathology (Zurich, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/14997935","citation_count":52,"is_preprint":false},{"pmid":"18521955","id":"PMC_18521955","title":"Discovery and characterization of three novel synuclein genes in zebrafish.","date":"2008","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/18521955","citation_count":46,"is_preprint":false},{"pmid":"34129723","id":"PMC_34129723","title":"Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in Alzheimer's disease.","date":"2021","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/34129723","citation_count":38,"is_preprint":false},{"pmid":"29370097","id":"PMC_29370097","title":"Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies.","date":"2018","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/29370097","citation_count":37,"is_preprint":false},{"pmid":"29282311","id":"PMC_29282311","title":"A Cellular MicroRNA Facilitates Regulatory T Lymphocyte Development by Targeting the FOXP3 Promoter TATA-Box Motif.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29282311","citation_count":37,"is_preprint":false},{"pmid":"19104444","id":"PMC_19104444","title":"Early-onset familial lewy body dementia with extensive tauopathy: a clinical, genetic, and neuropathological study.","date":"2009","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19104444","citation_count":32,"is_preprint":false},{"pmid":"9806846","id":"PMC_9806846","title":"Genomic organization and expression of the human beta-synuclein gene (SNCB).","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9806846","citation_count":30,"is_preprint":false},{"pmid":"36776048","id":"PMC_36776048","title":"Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer's Disease.","date":"2023","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/36776048","citation_count":30,"is_preprint":false},{"pmid":"19235732","id":"PMC_19235732","title":"Recapitulation of zebrafish sncga expression pattern and labeling the habenular complex in transgenic zebrafish using green fluorescent protein reporter gene.","date":"2009","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/19235732","citation_count":26,"is_preprint":false},{"pmid":"19929890","id":"PMC_19929890","title":"Clinical implications of subcategorizing BI-RADS 4 breast lesions associated with microcalcification: a radiology-pathology correlation study.","date":"2009","source":"The breast journal","url":"https://pubmed.ncbi.nlm.nih.gov/19929890","citation_count":24,"is_preprint":false},{"pmid":"38350954","id":"PMC_38350954","title":"CSF protein ratios with enhanced potential to reflect Alzheimer's disease pathology and neurodegeneration.","date":"2024","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/38350954","citation_count":19,"is_preprint":false},{"pmid":"36362437","id":"PMC_36362437","title":"Altered Expression of Genes Associated with Major Neurotransmitter Systems in the Reward-Related Brain Regions of Mice with Positive Fighting Experience.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36362437","citation_count":19,"is_preprint":false},{"pmid":"29808713","id":"PMC_29808713","title":"Age-related Beta-synuclein Alters the p53/Mdm2 Pathway and Induces the Apoptosis of Brain Microvascular Endothelial Cells In Vitro.","date":"2018","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/29808713","citation_count":17,"is_preprint":false},{"pmid":"17556099","id":"PMC_17556099","title":"Beta-synuclein gene variants and Parkinson's disease: a preliminary case-control study.","date":"2007","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/17556099","citation_count":16,"is_preprint":false},{"pmid":"32351728","id":"PMC_32351728","title":"Hydrogen Sulfide and β-Synuclein Are Involved and Interlinked in the Aging Glaucomatous Retina.","date":"2020","source":"Journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/32351728","citation_count":12,"is_preprint":false},{"pmid":"31368821","id":"PMC_31368821","title":"Convergent functional genomics of cocaine misuse in humans and animal models.","date":"2019","source":"The American journal of drug and alcohol abuse","url":"https://pubmed.ncbi.nlm.nih.gov/31368821","citation_count":12,"is_preprint":false},{"pmid":"27028825","id":"PMC_27028825","title":"[Changes in the Expression of Dopaminergic Genes in Brain Structures of Male Mice Exposed to Chronic Social Defeat Stress: An RNA-seq Study].","date":"2016","source":"Molekuliarnaia biologiia","url":"https://pubmed.ncbi.nlm.nih.gov/27028825","citation_count":10,"is_preprint":false},{"pmid":"29700768","id":"PMC_29700768","title":"Proteomic Analysis of Cerebral Cortex Extracts from Sus scrofa with Induced Hemorrhagic Stroke.","date":"2018","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/29700768","citation_count":10,"is_preprint":false},{"pmid":"31128101","id":"PMC_31128101","title":"Age-related distribution and potential role of SNCB in topographically different retinal areas of the common marmoset Callithrix jacchus, including the macula.","date":"2019","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/31128101","citation_count":7,"is_preprint":false},{"pmid":"11474193","id":"PMC_11474193","title":"Genomic organization, chromosome location, and expression analysis of mouse beta-synuclein, a candidate for involvement in neurodegeneration.","date":"2001","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11474193","citation_count":7,"is_preprint":false},{"pmid":"35416335","id":"PMC_35416335","title":"Golgin A7 family member B (GOLGA7B) is a plausible novel gene associating high glycaemic index diet with acne vulgaris.","date":"2022","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/35416335","citation_count":7,"is_preprint":false},{"pmid":"30040713","id":"PMC_30040713","title":"INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?","date":"2018","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/30040713","citation_count":6,"is_preprint":false},{"pmid":"37626939","id":"PMC_37626939","title":"Emergence of the Synucleins.","date":"2023","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/37626939","citation_count":6,"is_preprint":false},{"pmid":"31080399","id":"PMC_31080399","title":"Medullary Respiratory Circuit Is Reorganized by a Seasonally-Induced Program in Preparation for Hibernation.","date":"2019","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31080399","citation_count":6,"is_preprint":false},{"pmid":"38334615","id":"PMC_38334615","title":"Dementia with Lewy Bodies: Genomics, Transcriptomics, and Its Future with Data Science.","date":"2024","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/38334615","citation_count":5,"is_preprint":false},{"pmid":"32181667","id":"PMC_32181667","title":"Quantitative Proteomics Reveals Distinct Molecular Signatures of Different Cerebellum-Dependent Learning Paradigms.","date":"2020","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/32181667","citation_count":5,"is_preprint":false},{"pmid":"40301754","id":"PMC_40301754","title":"A genome-wide association study identified candidate genes associated with egg quality traits in Muscovy duck.","date":"2025","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/40301754","citation_count":5,"is_preprint":false},{"pmid":"33952343","id":"PMC_33952343","title":"Proteomic analysis of human frontal and temporal cortex using iTRAQ-based 2D LC-MS/MS.","date":"2021","source":"Chinese neurosurgical journal","url":"https://pubmed.ncbi.nlm.nih.gov/33952343","citation_count":3,"is_preprint":false},{"pmid":"40276598","id":"PMC_40276598","title":"High resilience of human cerebellum in Alzheimer's disease: reciprocal coupling of cellular anabolic and catabolic fluxes enable intensive neuroprotection.","date":"2025","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/40276598","citation_count":3,"is_preprint":false},{"pmid":"19343535","id":"PMC_19343535","title":"Molecular cloning, characterization and developmental expression of porcine beta-synuclein.","date":"2009","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/19343535","citation_count":2,"is_preprint":false},{"pmid":"38807289","id":"PMC_38807289","title":"Identification of Candidate Protein Biomarkers Associated with Domoic Acid Toxicosis in Cerebrospinal Fluid of California Sea Lions (Zalophus californianus).","date":"2024","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/38807289","citation_count":2,"is_preprint":false},{"pmid":"40974062","id":"PMC_40974062","title":"Genetic context of transgene insertion can influence neurodevelopment in zebrafish.","date":"2025","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40974062","citation_count":2,"is_preprint":false},{"pmid":"40093151","id":"PMC_40093151","title":"Genetic context of transgene insertion can influence neurodevelopment in zebrafish.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40093151","citation_count":2,"is_preprint":false},{"pmid":"38903914","id":"PMC_38903914","title":"Retinal ganglion cell type-specific expression of synuclein family members revealed by scRNA-sequencing.","date":"2024","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38903914","citation_count":1,"is_preprint":false},{"pmid":"38768940","id":"PMC_38768940","title":"Understanding Genetic Risks: Computational Exploration of Human β-Synuclein nsSNPs and their Potential Impact on Structural Alteration.","date":"2024","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/38768940","citation_count":1,"is_preprint":false},{"pmid":"39668376","id":"PMC_39668376","title":"CSF levels of brain-derived proteins correlate with brain ventricular volume in cognitively healthy 70-year-olds.","date":"2024","source":"Clinical proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/39668376","citation_count":1,"is_preprint":false},{"pmid":"37251917","id":"PMC_37251917","title":"Intragenic β-synuclein rearrangements in malignancy.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37251917","citation_count":0,"is_preprint":false},{"pmid":"41995712","id":"PMC_41995712","title":"Top-Down Proteomics of Zebrafish Brain Regions Using Capillary Zone Electrophoresis-Tandem Mass Spectrometry.","date":"2026","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/41995712","citation_count":0,"is_preprint":false},{"pmid":"41332695","id":"PMC_41332695","title":"Scalable Human Cellular Models of Parkinson's Disease Reveal A Druggable Link Between the Angiotensin Receptor 1 and α-Synuclein Pathology.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41332695","citation_count":0,"is_preprint":false},{"pmid":"22152908","id":"PMC_22152908","title":"[Role of genetics in the etiology of synucleinopathies].","date":"2011","source":"Revista espanola de geriatria y gerontologia","url":"https://pubmed.ncbi.nlm.nih.gov/22152908","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.11.18.689137","title":"Scalable Human Cellular Models of Parkinson’s Disease Reveal A Druggable Link Between the Angiotensin Receptor 1 and α-Synuclein Pathology","date":"2025-11-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.18.689137","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":26367,"output_tokens":1618,"usd":0.051686},"stage2":{"model":"claude-opus-4-6","input_tokens":4871,"output_tokens":3765,"usd":0.17772},"total_usd":0.229406,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Beta-synuclein (SNCB) and alpha-synuclein can both inhibit phospholipase D2 (PLD2) selectively, and SNCB is highly expressed in brain including the substantia nigra.\",\n      \"method\": \"Biochemical assay (PLD2 inhibition); Northern blot expression analysis\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single paper reporting biochemical inhibition activity, no mutagenesis or reconstitution with purified components described in this abstract\",\n      \"pmids\": [\"9806846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mouse beta-synuclein (Sncb) is co-expressed with alpha-synuclein at presynaptic nerve terminals and is subject to phosphorylation by Ca2+/calmodulin protein kinase II.\",\n      \"method\": \"Western blot, Northern blot, immunohistochemistry; kinase phosphorylation assay cited in context\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — phosphorylation by CaMKII cited as known fact in passing, not directly demonstrated in this paper; genomic/expression study primarily\",\n      \"pmids\": [\"11474193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Recombinant porcine beta-synuclein localizes to the cytoplasm when expressed in three different cell types.\",\n      \"method\": \"Subcellular fractionation / immunofluorescence of recombinant protein in transfected cells\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single paper, single method, no functional consequence linked to localization\",\n      \"pmids\": [\"19343535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Loss of beta-synuclein (sncb) and gamma1-synuclein (sncg1) in zebrafish results in hypokinesia and reduced dopamine levels, with delayed differentiation of dopaminergic neurons; these phenotypes are rescued by expression of human alpha-synuclein, demonstrating a phylogenetically conserved role for synucleins in dopamine homeostasis.\",\n      \"method\": \"Morpholino knockdown in zebrafish, behavioral assay (motor activity), dopamine measurement, rescue by human SNCA overexpression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean loss-of-function with defined cellular phenotype (dopamine levels, motor behavior) plus orthogonal rescue experiment; replicated across multiple synuclein knockdowns\",\n      \"pmids\": [\"22128150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Recombinant beta-synuclein (rSncb) treatment of brain microvascular endothelial cells activates PLD2 activity, triggers dose-dependent p53-mediated apoptosis (p19Arf increase, Mdm2 translocation, p53 activation), downregulates Snca expression, and modulates Akt phosphorylation; these effects were confirmed by siRNA knockdown of Sncb.\",\n      \"method\": \"Recombinant protein treatment, siRNA knockdown, viability/apoptosis assays, Western blot, RT-PCR, PLD2 activity assay\",\n      \"journal\": \"Cell transplantation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in single lab; siRNA confirmation of recombinant protein effects; but single lab, in vitro only\",\n      \"pmids\": [\"29808713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Recombinant SNCB exposure of retinal pigment epithelium (RPE) cells activates the PLD2-mediated p53 pathway, promotes senescence-related processes, and increases HMOX1 and NOX4 levels indicating oxidative stress and inflammatory responses; decreased apoptosis at lower concentrations suggests dose-dependent effects.\",\n      \"method\": \"Recombinant protein treatment of ARPE-19 and primary porcine RPE cells; apoptosis assays, Western blot, mRNA expression analysis\",\n      \"journal\": \"Experimental eye research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in single lab, consistent with findings from Brockhaus et al. 2018\",\n      \"pmids\": [\"31128101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SNCB is found fused in-frame with ETV6 in a pediatric T-cell ALL, with the rearrangement involving the C-terminal of beta-synuclein; the authors propose that rearranged SNCB may deregulate apoptosis via interaction with 14-3-3 proteins (based on known alpha-synuclein binding to 14-3-3).\",\n      \"method\": \"Genomic sequencing (clinical case), TCGA database analysis\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — mechanistic implication is computational/inferential; rearrangement identified but functional consequence not experimentally tested\",\n      \"pmids\": [\"37251917\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Beta-synuclein (SNCB) is a presynaptically localized, cytoplasmic brain protein that inhibits phospholipase D2 (PLD2) and acts as a negative regulator of alpha-synuclein aggregation; loss-of-function studies in zebrafish establish an essential conserved role in dopamine homeostasis and spontaneous motor behavior, while cell-based studies show that extracellular SNCB activates the PLD2/p53 pathway to modulate apoptosis and oxidative stress in endothelial and retinal epithelial cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"Beta-synuclein (SNCB) is a presynaptic, cytoplasmic brain protein that functions in dopamine neuron homeostasis and modulates phospholipase D2 (PLD2) signaling. SNCB selectively inhibits PLD2 activity in biochemical assays [PMID:9806846], and loss of sncb in zebrafish causes hypokinesia and reduced dopamine levels with delayed dopaminergic neuron differentiation—phenotypes rescued by human alpha-synuclein, establishing a conserved synuclein requirement for dopamine homeostasis [PMID:22128150]. Extracellular SNCB activates the PLD2/p19Arf/p53 apoptotic pathway in endothelial and retinal pigment epithelial cells in a dose-dependent manner, with concomitant modulation of Akt signaling and induction of oxidative stress markers HMOX1 and NOX4 [PMID:29808713, PMID:31128101].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing that SNCB possesses an intrinsic enzymatic regulatory activity—selective inhibition of PLD2—placed it alongside alpha-synuclein as a lipid-signaling modulator in the brain.\",\n      \"evidence\": \"Biochemical PLD2 inhibition assay and Northern blot expression profiling in human tissues\",\n      \"pmids\": [\"9806846\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Inhibition not reconstituted with fully purified components or confirmed by mutagenesis\",\n        \"Physiological relevance of PLD2 inhibition in neurons not tested\",\n        \"Relationship between PLD2 inhibition and synuclein aggregation unknown\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstration that SNCB co-localizes with alpha-synuclein at presynaptic terminals and is a CaMKII substrate pointed to regulated post-translational modification at synapses, though phosphorylation was not directly demonstrated in this study.\",\n      \"evidence\": \"Western blot, Northern blot, immunohistochemistry in mouse brain\",\n      \"pmids\": [\"11474193\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"CaMKII phosphorylation cited as prior knowledge, not directly shown here\",\n        \"Functional consequence of SNCB phosphorylation on its PLD2-inhibitory or anti-aggregation activity unknown\",\n        \"Stoichiometry and site of phosphorylation not mapped\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Confirming cytoplasmic localization of SNCB across multiple cell types established that, like alpha-synuclein, it is a soluble cytosolic protein rather than membrane-anchored.\",\n      \"evidence\": \"Subcellular fractionation and immunofluorescence of recombinant porcine SNCB in transfected cells\",\n      \"pmids\": [\"19343535\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Single study, single method class; no confirmation of endogenous protein localization in neurons\",\n        \"Dynamic membrane association under stimulation not assessed\",\n        \"Functional link between localization and activity not established\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Loss-of-function studies in zebrafish answered whether SNCB is required in vivo: sncb knockdown caused hypokinesia and reduced dopamine, and rescue by human alpha-synuclein proved a conserved synuclein requirement for dopaminergic neuron function.\",\n      \"evidence\": \"Morpholino knockdown in zebrafish with behavioral assay, dopamine measurement, and rescue by human SNCA overexpression\",\n      \"pmids\": [\"22128150\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mammalian genetic knockout phenotype not reported\",\n        \"Whether SNCB's dopamine role depends on PLD2 inhibition not tested\",\n        \"Mechanism of delayed dopaminergic neuron differentiation unresolved\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extracellular SNCB was shown to activate (not inhibit) PLD2 in endothelial cells and to trigger p19Arf/Mdm2/p53-mediated apoptosis, revealing a context-dependent signaling axis distinct from the inhibitory activity seen in biochemical assays.\",\n      \"evidence\": \"Recombinant SNCB treatment and siRNA knockdown in brain microvascular endothelial cells; viability/apoptosis assays, Western blot, PLD2 activity assay\",\n      \"pmids\": [\"29808713\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Discrepancy between PLD2 inhibition (1998) and activation (2018) not mechanistically reconciled\",\n        \"Whether extracellular SNCB acts via a receptor or direct membrane interaction unknown\",\n        \"In vivo relevance of extracellular SNCB in vasculature not established\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Replication of the PLD2/p53 pathway activation by extracellular SNCB in a second cell type (retinal pigment epithelium) extended the model to include oxidative stress induction via HMOX1 and NOX4, linking SNCB to senescence-associated processes.\",\n      \"evidence\": \"Recombinant SNCB treatment of ARPE-19 and primary porcine RPE cells; apoptosis assays, Western blot, mRNA expression analysis\",\n      \"pmids\": [\"31128101\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether SNCB is physiologically present extracellularly at sufficient concentrations remains undemonstrated\",\n        \"No genetic loss-of-function corroboration for the oxidative stress phenotype\",\n        \"Dose-dependent switch between anti- and pro-apoptotic effects not mechanistically explained\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The mechanism by which SNCB supports dopaminergic neuron function in vivo, whether this depends on PLD2 regulation, and how extracellular versus intracellular SNCB activities are integrated remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No mammalian Sncb knockout phenotype reported in the literature\",\n        \"No structural model of SNCB–PLD2 interaction\",\n        \"Receptor or uptake mechanism for extracellular SNCB unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005357801\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PLD2\"],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to fix a pathway term_id. Let me correct:\n\n```json\n{\n  \"mechanistic_narrative\": \"Beta-synuclein (SNCB) is a presynaptic, cytoplasmic brain protein that functions in dopamine neuron homeostasis and modulates phospholipase D2 (PLD2) signaling. SNCB selectively inhibits PLD2 activity in biochemical assays [PMID:9806846], and loss of sncb in zebrafish causes hypokinesia and reduced dopamine levels with delayed dopaminergic neuron differentiation—phenotypes rescued by human alpha-synuclein, establishing a conserved synuclein requirement for dopamine homeostasis [PMID:22128150]. Extracellular SNCB activates the PLD2/p19Arf/p53 apoptotic pathway in endothelial and retinal pigment epithelial cells in a dose-dependent manner, with concomitant modulation of Akt signaling and induction of oxidative stress markers HMOX1 and NOX4 [PMID:29808713, PMID:31128101].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing that SNCB possesses an intrinsic enzymatic regulatory activity—selective inhibition of PLD2—placed it alongside alpha-synuclein as a lipid-signaling modulator in the brain.\",\n      \"evidence\": \"Biochemical PLD2 inhibition assay and Northern blot expression profiling in human tissues\",\n      \"pmids\": [\"9806846\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Inhibition not reconstituted with fully purified components or confirmed by mutagenesis\",\n        \"Physiological relevance of PLD2 inhibition in neurons not tested\",\n        \"Relationship between PLD2 inhibition and synuclein aggregation unknown\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstration that SNCB co-localizes with alpha-synuclein at presynaptic terminals and is a CaMKII substrate pointed to regulated post-translational modification at synapses, though phosphorylation was not directly demonstrated in this study.\",\n      \"evidence\": \"Western blot, Northern blot, immunohistochemistry in mouse brain\",\n      \"pmids\": [\"11474193\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"CaMKII phosphorylation cited as prior knowledge, not directly shown here\",\n        \"Functional consequence of SNCB phosphorylation on its PLD2-inhibitory or anti-aggregation activity unknown\",\n        \"Stoichiometry and site of phosphorylation not mapped\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Confirming cytoplasmic localization of SNCB across multiple cell types established that, like alpha-synuclein, it is a soluble cytosolic protein rather than membrane-anchored.\",\n      \"evidence\": \"Subcellular fractionation and immunofluorescence of recombinant porcine SNCB in transfected cells\",\n      \"pmids\": [\"19343535\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Single study, single method class; no confirmation of endogenous protein localization in neurons\",\n        \"Dynamic membrane association under stimulation not assessed\",\n        \"Functional link between localization and activity not established\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Loss-of-function studies in zebrafish answered whether SNCB is required in vivo: sncb knockdown caused hypokinesia and reduced dopamine, and rescue by human alpha-synuclein proved a conserved synuclein requirement for dopaminergic neuron function.\",\n      \"evidence\": \"Morpholino knockdown in zebrafish with behavioral assay, dopamine measurement, and rescue by human SNCA overexpression\",\n      \"pmids\": [\"22128150\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mammalian genetic knockout phenotype not reported\",\n        \"Whether SNCB's dopamine role depends on PLD2 inhibition not tested\",\n        \"Mechanism of delayed dopaminergic neuron differentiation unresolved\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extracellular SNCB was shown to activate (not inhibit) PLD2 in endothelial cells and to trigger p19Arf/Mdm2/p53-mediated apoptosis, revealing a context-dependent signaling axis distinct from the inhibitory activity seen in biochemical assays.\",\n      \"evidence\": \"Recombinant SNCB treatment and siRNA knockdown in brain microvascular endothelial cells; viability/apoptosis assays, Western blot, PLD2 activity assay\",\n      \"pmids\": [\"29808713\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Discrepancy between PLD2 inhibition (1998) and activation (2018) not mechanistically reconciled\",\n        \"Whether extracellular SNCB acts via a receptor or direct membrane interaction unknown\",\n        \"In vivo relevance of extracellular SNCB in vasculature not established\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Replication of the PLD2/p53 pathway activation by extracellular SNCB in a second cell type (retinal pigment epithelium) extended the model to include oxidative stress induction via HMOX1 and NOX4, linking SNCB to senescence-associated processes.\",\n      \"evidence\": \"Recombinant SNCB treatment of ARPE-19 and primary porcine RPE cells; apoptosis assays, Western blot, mRNA expression analysis\",\n      \"pmids\": [\"31128101\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether SNCB is physiologically present extracellularly at sufficient concentrations remains undemonstrated\",\n        \"No genetic loss-of-function corroboration for the oxidative stress phenotype\",\n        \"Dose-dependent switch between anti- and pro-apoptotic effects not mechanistically explained\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The mechanism by which SNCB supports dopaminergic neuron function in vivo, whether this depends on PLD2 regulation, and how extracellular versus intracellular SNCB activities are integrated remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No mammalian Sncb knockout phenotype reported in the literature\",\n        \"No structural model of SNCB–PLD2 interaction\",\n        \"Receptor or uptake mechanism for extracellular SNCB unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PLD2\"],\n    \"other_free_text\": []\n  }\n}\n```"}